Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies

Area of Science:

• Natural product chemistry
• Hematology
• Cancer research

Background:

• Resveratrol, a polyphenol, exhibits promising preclinical anti-cancer activity.
• Interest in resveratrol for various diseases, including cancer, is high.
• Resveratrol demonstrates potent in vitro inhibitory activity against blood cancer cell lines.

Purpose of the Study:

• To review scientific evidence supporting resveratrol's utility in hematological malignancies.
• To explore resveratrol's therapeutic potential in managing blood cancers.
• To suggest potential clinical trials for resveratrol in hematology.

Main Methods:

• Review of preclinical and pharmacological studies on resveratrol.
• Analysis of resveratrol's in vitro anti-tumor activity.
• Investigation of resveratrol's bioavailability and distribution.

Main Results:

• Resveratrol is safe for human use but has poor oral bioavailability due to hepatic metabolism.
• A significant amount of orally administered resveratrol reaches the bone marrow.
• Resveratrol targets pathways dysregulated in blood cancers.

Conclusions:

• Resveratrol shows potential for managing select hematological malignancies.
• Further research and clinical trials are warranted to explore resveratrol's efficacy.
• Resveratrol's ability to target cancer pathways supports its investigation in blood cancers.